Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) — Capital Reinvestment Ratio
Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) has a Capital Reinvestment Ratio of 0.82x as of December 2024, meaning it reinvests 1% of its operating cash flow (CN¥102.67 Million) in capital expenditures (CN¥83.91 Million). Check how tangible is Xinxiang Tuoxin Pharmaceutical Co.Ltd.'s equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Xinxiang Tuoxin Pharmaceutical Co.Ltd. Capital Reinvestment Ratio (2019–2024)
This chart tracks Xinxiang Tuoxin Pharmaceutical Co.Ltd.'s Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see 301089 operating cash flow.
Annual Capital Reinvestment Ratio for Xinxiang Tuoxin Pharmaceutical Co.Ltd. (2019–2024)
Year-by-year Capital Reinvestment Ratio for Xinxiang Tuoxin Pharmaceutical Co.Ltd. from 2019 to 2024. See Xinxiang Tuoxin Pharmaceutical Co.Ltd. free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.82x | CN¥102.67 Million | CN¥83.91 Million | ▼ -88.1% |
| 2023 | 6.87x | CN¥26.95 Million | CN¥185.22 Million | ▲ +1145.5% |
| 2022 | 0.55x | CN¥268.85 Million | CN¥148.33 Million | ▼ -71.5% |
| 2021 | 1.94x | CN¥58.19 Million | CN¥112.73 Million | ▲ +213.6% |
| 2020 | 0.62x | CN¥120.00 Million | CN¥74.12 Million | ▼ -30.0% |
| 2019 | 0.88x | CN¥86.38 Million | CN¥76.20 Million | — |